CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis
- PMID: 30835006
- DOI: 10.1007/s10147-019-01403-3
CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis
Abstract
Introduction: To systematically analyze CT and clinical characteristics to find out the risk factors of epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC). Then the significant characteristics were used to set up a mathematic model to predict EGFR mutation in NSCLC.
Materials and methods: PubMed, Web of Knowledge and EMBASE up to August 17, 2018 were systematically searched for relevant studies that investigated the evidence of association between CT and clinical characteristics and EGFR mutation in NSCLC. After study selection, data extraction, and quality assessment, the pooled odds ratios (ORs) were calculated. Then from May 2017 to August 2018, all NSCLC received EGFR mutation examination and CT examination in our hospital were chosen to test the prediction model by receiver operating characteristic (ROC) curves.
Results: Seventeen original studies met the inclusion criteria. The results showed that the ORs of ground-glass opacity (GGO), air bronchogram, pleural retraction, vascular convergence, smoking history, female gender were, respectively, 1.93 (P = 0.003), 2.09 (P = 0.03), 1.59 (P < 0.01), 1.61 (P = 0.001), 0.28 (P < 0.01), 0.35 (P < 0.01). The result of speculation, cavitation/bubble-like lucency, lesion shape, margin, pathological stage were, respectively, 1.19 (P = 0.32), 0.99 (P = 0.97), 0.82 (P = 0.42), 1.02 (P = 0.90), 0.77 (P = 0.30). 121 NSCLC received EGFR mutation test were included to test the prediction model. The mathematical model based on the results of meta-analysis was: 0.74 × air bronchogram + 0.46 × pleural retraction + 0.48 × vascular convergence - 1.27 × non-smoking history - 1.05 × female. The area under the ROC curve was 0.68.
Conclusion: Based on the current evidence, GGO presence, air bronchogram, pleural retraction, vascular convergence were significant risk factors of EGFR mutation in NSCLC. And the prediction model can help to predict EGFR mutation status.
Keywords: Epidermal growth factor receptor; Meta-analysis; Non-small cell lung carcinoma; Spiral computed tomography.
Similar articles
-
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.Eur Radiol. 2016 Jan;26(1):32-42. doi: 10.1007/s00330-015-3814-0. Epub 2015 May 9. Eur Radiol. 2016. PMID: 25956936
-
Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.Eur J Radiol. 2019 Jan;110:148-155. doi: 10.1016/j.ejrad.2018.11.032. Epub 2018 Nov 28. Eur J Radiol. 2019. PMID: 30599853
-
CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.Radiology. 2016 Jul;280(1):271-80. doi: 10.1148/radiol.2016151455. Epub 2016 Mar 3. Radiology. 2016. PMID: 26937803 Free PMC article.
-
Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.Clin Lung Cancer. 2019 Sep;20(5):339-349. doi: 10.1016/j.cllc.2019.05.006. Epub 2019 May 11. Clin Lung Cancer. 2019. PMID: 31164317
-
Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.Br J Radiol. 2021 Jun 1;94(1122):20201272. doi: 10.1259/bjr.20201272. Epub 2021 May 12. Br J Radiol. 2021. PMID: 33882244 Free PMC article.
Cited by
-
Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma.Clin Transl Oncol. 2024 Jun;26(6):1438-1445. doi: 10.1007/s12094-023-03366-4. Epub 2024 Jan 9. Clin Transl Oncol. 2024. PMID: 38194018
-
Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis.BMJ Open. 2021 Jun 8;11(6):e044313. doi: 10.1136/bmjopen-2020-044313. BMJ Open. 2021. PMID: 34103313 Free PMC article.
-
Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges.J Pers Med. 2022 Mar 16;12(3):480. doi: 10.3390/jpm12030480. J Pers Med. 2022. PMID: 35330479 Free PMC article. Review.
-
Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.Int J Gen Med. 2021 Jul 21;14:3687-3698. doi: 10.2147/IJGM.S316344. eCollection 2021. Int J Gen Med. 2021. PMID: 34321914 Free PMC article.
-
The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma.EJNMMI Res. 2023 Apr 4;13(1):26. doi: 10.1186/s13550-023-00977-4. EJNMMI Res. 2023. PMID: 37014500 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous